Cloning and Expression of NS3 Gene of Pakistani Isolate Type 2 Dengue Virus

Abstract Introduction Dengue is one of the major emerging viral diseases in the world, with dramatic increases in reported cases in the last few decades and annual worldwide occurrence of approximately 390 million infections. It is a highly important mosquito-vectored disease and is a problem in tropical and subtropical areas of the world. The major aim of this study was to clone and express the dengue NS3 gene, in service to its therapeutic importance for the development of stable cell lines. Material and Methods Blood samples from dengue fever (DF) patients were collected and subjected to PCR amplification of the NS3 gene of dengue virus serotype-2 (DENV-2). The NS3 gene was amplified using gene specific primers and cloned in the TA cloning vectors. Results The gene was successfully expressed in mammalian expression vector pcDNA3.1. The current finding was different from a previously reported DENV-2 strain replicon constructed in different cells, in which the whole genetic material of the virus was used instead of an active protease gene, and which gave a low yield of replicon expressing cells. Conclusion Recombinant NS3 could be used to produce an antibody that is possibly helpful for developing a single step diagnostic assay to detect the dengue virus NS3 antigen in sera of dengue patients.

[1]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[2]  Chayakom Phurimsak,et al.  THE INHIBITORY ACTIONS OF HOUTTUYNIA CORDATA AQUEOUS EXTRACT ON DENGUE VIRUS AND DENGUE‐INFECTED CELLS , 2012 .

[3]  M. A. Rai Epidemic: Control of dengue fever in Pakistan , 2011, Nature.

[4]  J. Hoffman Q&A: The outsider insider , 2011, Nature.

[5]  O. Ullah,et al.  Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan , 2011, BMC Microbiology.

[6]  F. Jahan Dengue Fever (DF) in Pakistan , 2011, Asia Pacific family medicine.

[7]  D. A. Stein,et al.  High-content assay to identify inhibitors of dengue virus infection. , 2010, Assay and drug development technologies.

[8]  E. Khan,et al.  Demographic and Clinical Features of Dengue Fever in Pakistan from 2003–2007: A Retrospective Cross-Sectional Study , 2010, PloS one.

[9]  Satheesh Natarajan NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus , 2010, Genetics and molecular biology.

[10]  D. Gubler,et al.  Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development , 2010, Current infectious disease reports.

[11]  Robin Palotai,et al.  Community Landscapes: An Integrative Approach to Determine Overlapping Network Module Hierarchy, Identify Key Nodes and Predict Network Dynamics , 2009, PloS one.

[12]  Ting Xu,et al.  Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. , 2008, Antiviral research.

[13]  R. Hewson,et al.  Co-circulations of two genotypes of dengue virus in 2006 out-break of dengue hemorrhagic fever in Karachi, Pakistan. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  G. Chang,et al.  Detection and Serotyping of Dengue Virus in Serum Samples by Multiplex Reverse Transcriptase PCR-Ligase Detection Reaction Assay , 2008, Journal of Clinical Microbiology.

[15]  C. Rice,et al.  The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication , 2007, Journal of Virology.

[16]  David W. Russell,et al.  The inoue method for preparation and transformation of competent e. Coli: "ultra-competent" cells. , 2006, CSH protocols.

[17]  Yen-Liang Chen,et al.  Finding new medicines for flaviviral targets. , 2006, Novartis Foundation symposium.

[18]  A. Nisalak,et al.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, The Journal of infectious diseases.

[19]  R. Padmanabhan,et al.  Expression, purification, and characterization of the RNA 5'-triphosphatase activity of dengue virus type 2 nonstructural protein 3. , 2002, Virology.

[20]  D. Vaughn,et al.  Dengue: an escalating problem , 2002, BMJ : British Medical Journal.

[21]  T. Takasu,et al.  Dengue virus infection among children with undifferentiated fever in Karachi , 1998, Indian journal of pediatrics.

[22]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever. , 2014 .

[23]  K E Ebner,et al.  Cotranslational Membrane Insertion of the Serine Proteinase Precursor NS2B-NS3(Pro) of Dengue Virus Type 2 Is Required for Efficient in Vitro Processing and Is Mediated through the Hydrophobic Regions of NS2B* , 1997, The Journal of Biological Chemistry.

[24]  H. C. Tan,et al.  Dengue haemorrhagic fever outbreak in Karachi, Pakistan, 1994. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  R. Miller,et al.  Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity , 1993, Journal of virology.